Fei Zhao
- Cancer Research top 10%
- MicroRNA in disease regulation 7
- Immunology top 10%
- Reproductive System and Pregnancy 13
- Reproductive Medicine top 5%
- Endometriosis Research and Treatment 7
- Nephrology top 5%
- Renal Diseases and Glomerulopathies 6
- Neurology top 10%
-
- Renal and related cancers 15
-
- Reproductive Biology and Fertility 8
-
- Lung Cancer Diagnosis and Treatment 6
-
- Estrogen and related hormone effects 5
- Journals
- SHILAP Revista de lepidopterología (1 paper)PLoS ONE (2 papers)Nature Methods (1 paper)
- Partner nations
- ChinaUnited StatesJapan
In The Last Decade
Fei Zhao
93 papers receiving 1.7k citations
Peers
Comparison fields: 5 of 132
- Cancer Research 298
- Immunology 366
- Reproductive Medicine 130
- Nephrology 96
- Neurology 86
Countries citing papers authored by Fei Zhao
This map shows the geographic impact of Fei Zhao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fei Zhao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fei Zhao more than expected).
Fields of papers citing papers by Fei Zhao
This network shows the impact of papers produced by Fei Zhao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fei Zhao. The network helps show where Fei Zhao may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Fei Zhao, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 2 | |
| 3 | 2024 | 1 | |
| 4 | 2023 | 4 | |
| 5 | 2023 | 6 | |
| 6 | 2022 | 0 | |
| 7 | 2022 | 105 | |
| 8 | 2022 | 4 | |
| 9 | 2022 | 7 | |
| 10 | 2022 | 3 | |
| 11 | 2021 | 86 | |
| 12 | 2020 | 61 | |
| 13 | 2020 | 4 | |
| 14 | 2018 | 1 | |
| 15 | 2017 | 73 | |
| 16 | 2016 | 4 | |
| 17 | 2016 | 21 | |
| 18 | 2013 | 8 | |
| 19 | 2013 | 32 | |
| 20 | 2013 | 36 |
About Fei Zhao
Fei Zhao is a scholar working on Nephrology, Reproductive Medicine and Immunology, having authored 98 papers that have together received 1.7k indexed citations. Recurring topics across this work include Renal and related cancers (15 papers), Reproductive System and Pregnancy (13 papers), Reproductive Biology and Fertility (8 papers), MicroRNA in disease regulation (7 papers), Endometriosis Research and Treatment (7 papers), Renal Diseases and Glomerulopathies (6 papers), Lung Cancer Diagnosis and Treatment (6 papers) and Estrogen and related hormone effects (5 papers). The work is most often cited by research in Cancer Research (298 citations), Immunology (366 citations) and Reproductive Medicine (130 citations). Fei Zhao has collaborated with scholars based in China, United States and Japan. Frequent co-authors include Xiaoqin Ye, Honglu Diao, Shuo Xiao, Rong Li, Chuwen Chen, Lihua Xu, Xi‐Yuan Ge, Wenwen Yang, Rong Li and Michael P. Manns. Their work appears in journals such as SHILAP Revista de lepidopterología, PLoS ONE and Nature Methods.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.